Dr. Sylvia Norman founded Sandhill Crane Diagnostics, Inc. in 2016 developing technology to enable delivery of rapid, portable and wireless medical diagnostic testing performed at point-of-care. She has 20+ years of experience in the biotechnology industry, developing diagnostic assays and medical device products for FDA and CLIA approval. Prior to Sandhill Crane Diagnostics, she founded Molecular Diagnostics Consulting working with biotechnology startups and served as CSO for Cellgen Diagnostics developing a nanotechnology-based companion diagnostics platform. Sylvia is now utilizing her expertise in molecular diagnostics, nanotechnology and genetics to develop a novel rapid diagnostic testing platform with a menu of tests focused on women’s health and chronic diseases.
Neeraj has twenty years of experience in the biotechnology and healthcare industries. His career has spanned everything from co-founding a venture-backed tech startup to leading global business development efforts at publicly traded biotechnology companies. Neeraj most recently co-founded and was the Chief Operating Officer at Insitome, a consumer genomics startup based in Austin, Texas. Prior to Insitome, Neeraj held business development roles at life science and healthcare companies including Illumina, Luminex, RainTree Oncology (acquired by Cardinal Health), and Insight Genetics. At Illumina, he was the business development lead for the team that developed and launched BaseSpace, the first cloud-based data analysis platform for next-generation sequencing research. He also helped commercialize Illumina’s first direct-to-consumer, whole genome sequencing offering and first single-cell isolation and genomic analysis service. As the Director of Partner Operations at Luminex, he managed over 20 global partnerships in the life science and applied research markets that contributed >$35M in top-line revenue. His responsibilities included leading product launches and complex agreement negotiations with partners like Millipore, Bio-Rad, and Thermo Fisher. Neeraj previously held a variety of biotech R&D roles at ag-bio, drug discovery, and oncology diagnostic companies.